(Q45202562)

10 December 2017

title

Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosets (English)

1 reference

10 December 2017

1 reference

6

C D Marsden

1 reference

10 December 2017

P A Löschmann

1

1 reference

10 December 2017

L A Smith

2

1 reference

10 December 2017

K W Lange

3

1 reference

10 December 2017

P Jähnig

4

1 reference

10 December 2017

P Jenner

5

1 reference

10 December 2017

publication date

1 January 1992

1 reference

10 December 2017

number of pages

8

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

10 December 2017

volume

109

1 reference

10 December 2017

issue

1-2

1 reference

10 December 2017

page(s)

49-56

1 reference

Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease

10 December 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245479

Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245479

Assessment of grooming and other behavioural responses to the D-1 dopamine receptor agonist SK & F 38393 and its R- and S-enantiomers in the intact adult rat

21 January 2018

1 reference

12 December 2020

Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390

1 reference

12 December 2020

Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393.

1 reference

12 December 2020

The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmoset

1 reference

12 December 2020

Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

1 reference

12 December 2020

Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors

1 reference

12 December 2020

Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease

1 reference

12 December 2020

Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.

1 reference

12 December 2020

Multiple receptors for dopamine

1 reference

12 December 2020

Synergistic interaction between dopamine D-1 and D-2 receptor agonists: circling behaviour of rats with hemitransection

1 reference

12 December 2020

CY 208–243 behaves as a typical D-1 agonist in the reserpine-treated mouse

1 reference

12 December 2020

Behavioral correlations of dopamine receptor activation

1 reference

12 December 2020

The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset

1 reference

12 December 2020

Motor depression: a new role for D1 receptors?

1 reference

12 December 2020

Effect of D1 receptor stimulation in normal and MPTP monkeys

1 reference

12 December 2020

Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets

1 reference

12 December 2020

Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway

1 reference

12 December 2020

Dopaminergic mechanisms in hemiparkinsonian monkeys

1 reference

12 December 2020

Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors

1 reference

12 December 2020

D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

1 reference

12 December 2020

Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502

1 reference

12 December 2020

Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions

1 reference

12 December 2020

Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393

1 reference

12 December 2020

Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

1 reference

12 December 2020

Selective D-1 dopamine receptor agonist treatment of Parkinson's disease

1 reference

12 December 2020

Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.

1 reference

12 December 2020

The d-1 dopamine receptor and the search for its functional role: from neurochemistry to behaviour

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245479

1 reference

Dimensions Publication ID

10 December 2017

1033377546

0 references

1 reference